210 related articles for article (PubMed ID: 30353102)
41. MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma.
Bissey PA; Teng M; Law JH; Shi W; Bruce JP; Petit V; Tsao SW; Yip KW; Liu FF
BMC Cancer; 2020 Jun; 20(1):597. PubMed ID: 32586280
[TBL] [Abstract][Full Text] [Related]
42. Downregulation of ABI2 expression by EBV-miR-BART13-3p induces epithelial-mesenchymal transition of nasopharyngeal carcinoma cells through upregulation of c-JUN/SLUG signaling.
Huang J; Qin Y; Yang C; Wan C; Dai X; Sun Y; Meng J; Lu Y; Li Y; Zhang Z; Wu B; Xu S; Jin H; Yang K
Aging (Albany NY); 2020 Jan; 12(1):340-358. PubMed ID: 31907338
[TBL] [Abstract][Full Text] [Related]
43. Long noncoding RNA LINC00460 aggravates invasion and metastasis by targeting miR-30a-3p/Rap1A in nasopharyngeal carcinoma.
Hu X; Liu W; Jiang X; Wang B; Li L; Wang J; Ma J
Hum Cell; 2019 Oct; 32(4):465-476. PubMed ID: 31414345
[TBL] [Abstract][Full Text] [Related]
44. Crucifera sulforaphane (SFN) inhibits the growth of nasopharyngeal carcinoma through DNA methyltransferase 1 (DNMT1)/Wnt inhibitory factor 1 (WIF1) axis.
Chen L; Chan LS; Lung HL; Yip TTC; Ngan RKC; Wong JWC; Lo KW; Ng WT; Lee AWM; Tsao GSW; Lung ML; Mak NK
Phytomedicine; 2019 Oct; 63():153058. PubMed ID: 31394414
[TBL] [Abstract][Full Text] [Related]
45. VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma.
Liang Z; Liu Z; Cheng C; Wang H; Deng X; Liu J; Liu C; Li Y; Fang W
Cell Death Dis; 2019 Apr; 10(4):305. PubMed ID: 30944308
[TBL] [Abstract][Full Text] [Related]
46. LncRNA SNHG15 promotes the proliferation of nasopharyngeal carcinoma via sponging miR-141-3p to upregulate KLF9.
Yi TW; Lv XX; Fan H; Zan N; Su XD
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6744-6751. PubMed ID: 32633365
[TBL] [Abstract][Full Text] [Related]
47. Elevation of MiR-9-3p suppresses the epithelial-mesenchymal transition of nasopharyngeal carcinoma cells via down-regulating FN1, ITGB1 and ITGAV.
Ding Y; Pan Y; Liu S; Jiang F; Jiao J
Cancer Biol Ther; 2017 Jun; 18(6):414-424. PubMed ID: 28613134
[TBL] [Abstract][Full Text] [Related]
48. MicroRNA-449b-5p suppresses cell proliferation, migration and invasion by targeting TPD52 in nasopharyngeal carcinoma.
Yin W; Shi L; Mao Y
J Biochem; 2019 Nov; 166(5):433-440. PubMed ID: 31350893
[TBL] [Abstract][Full Text] [Related]
49. EZH2-mediated H3K27me3 enrichment on the lncRNA MEG3 promoter regulates the growth and metastasis of glioma cells by regulating miR-21-3p.
Qin WX; Shi Y; Zhu D; Li YP; Chen YH; Cui J; Cui GY; Pan JX; Ren ZY
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3204-3214. PubMed ID: 32271438
[TBL] [Abstract][Full Text] [Related]
50. miR-375 Inhibits the Proliferation and Invasion of Nasopharyngeal Carcinoma Cells by Suppressing PDK1.
Jia-Yuan X; Wei S; Fang-Fang L; Zhi-Jian D; Long-He C; Sen L
Biomed Res Int; 2020; 2020():9704245. PubMed ID: 32280708
[TBL] [Abstract][Full Text] [Related]
51. MiR-185-3p and miR-324-3p Predict Radiosensitivity of Nasopharyngeal Carcinoma and Modulate Cancer Cell Growth and Apoptosis by Targeting SMAD7.
Xu J; Ai Q; Cao H; Liu Q
Med Sci Monit; 2015 Sep; 21():2828-36. PubMed ID: 26390174
[TBL] [Abstract][Full Text] [Related]
52. MircoRNA-629 promotes proliferation, invasion and migration of nasopharyngeal carcinoma through targeting PDCD4.
Zheng YQ; Bai YF; Yang S; Cui YR; Wang YP; Hu WL
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):207-216. PubMed ID: 30657562
[TBL] [Abstract][Full Text] [Related]
53. MiR-29c suppresses invasion and metastasis by targeting TIAM1 in nasopharyngeal carcinoma.
Liu N; Tang LL; Sun Y; Cui RX; Wang HY; Huang BJ; He QM; Jiang W; Ma J
Cancer Lett; 2013 Feb; 329(2):181-8. PubMed ID: 23142282
[TBL] [Abstract][Full Text] [Related]
54. EZH2 promotes angiogenesis through inhibition of miR-1/Endothelin-1 axis in nasopharyngeal carcinoma.
Lu J; Zhao FP; Peng Z; Zhang MW; Lin SX; Liang BJ; Zhang B; Liu X; Wang L; Li G; Tian WD; Peng Y; He ML; Li XP
Oncotarget; 2014 Nov; 5(22):11319-32. PubMed ID: 25237831
[TBL] [Abstract][Full Text] [Related]
55. The tumor-suppressive role of microRNA-873 in nasopharyngeal carcinoma correlates with downregulation of ZIC2 and inhibition of AKT signaling pathway.
Lv B; Li F; Liu X; Lin L
Cancer Gene Ther; 2021 Feb; 28(1-2):74-88. PubMed ID: 32555352
[TBL] [Abstract][Full Text] [Related]
56. S100A14 suppresses metastasis of nasopharyngeal carcinoma by inhibition of NF-kB signaling through degradation of IRAK1.
Meng DF; Sun R; Liu GY; Peng LX; Zheng LS; Xie P; Lin ST; Mei Y; Qiang YY; Li CZ; Xu L; Peng XS; Hu H; Lang YH; Liu ZJ; Wang MD; Guo LL; Xie DH; Shu DT; Li HF; Luo FF; Niu XT; Huang BJ; Qian CN
Oncogene; 2020 Jul; 39(30):5307-5322. PubMed ID: 32555330
[TBL] [Abstract][Full Text] [Related]
57. EZH2 suppresses the nucleotide excision repair in nasopharyngeal carcinoma by silencing XPA gene.
Huang Y; Wang X; Niu X; Wang X; Jiang R; Xu T; Liu Y; Liang L; Ou X; Xing X; Li W; Hu C
Mol Carcinog; 2017 Feb; 56(2):447-463. PubMed ID: 27253463
[TBL] [Abstract][Full Text] [Related]
58. HIF-1α downregulation of miR-433-3p in adipocyte-derived exosomes contributes to NPC progression via targeting SCD1.
Yin H; Qiu X; Shan Y; You B; Xie L; Zhang P; Zhao J; You Y
Cancer Sci; 2021 Apr; 112(4):1457-1470. PubMed ID: 33511729
[TBL] [Abstract][Full Text] [Related]
59. Resveratrol Suppresses Human Nasopharyngeal Carcinoma Cell Growth Via Inhibiting Differentiation Antagonizing Non-Protein Coding RNA (DANCR) Expression.
Zhang J; Jin X; Zhou C; Zhao H; He P; Hao Y; Dong Q
Med Sci Monit; 2020 Jul; 26():e923622. PubMed ID: 32683392
[TBL] [Abstract][Full Text] [Related]
60. Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway.
Yu C; Chen L; Yie L; Wei L; Wen T; Liu Y; Chen H
Oncol Rep; 2015 May; 33(5):2402-10. PubMed ID: 25738652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
